Company / Current Liabilities per Share
LEXICON PHARMACEUTICALS, INC. Current Liabilities per Share History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.06
FY2025
5-year range
$0.06 / $0.35
FY2021-FY2025
Trend
-78.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.06 in FY2013 to $2.16 in FY2016.
Based on SEC 10-K filings.
0.06 in FY2025 with a 10-year CAGR of -28.6%.
Improved from $0.22 to $0.06 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -28.6%
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 78.9% year-over-year.
- Peak current liabilities per share was recorded in FY2016.
- Lowest current liabilities per share in the period was in FY2013.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.06 | -78.9% |
| FY2024 | $0.27 | +26.1% |
| FY2023 | $0.22 | -1.2% |
| FY2019 | $0.22 | -38.0% |
| FY2018 | $0.35 | -70.5% |
| FY2017 | $1.20 | -44.4% |
| FY2016 | $2.16 | +28.5% |
| FY2015 | $1.68 | +1727.3% |
| FY2014 | $0.09 | +62.2% |
| FY2013 | $0.06 | -6.2% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026